SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products.  Break WaveTM will fragment large kidney stones faster, safer and more effectively than existing options and with the goal of eliminating general anesthesia and ionizing x-ray radiation from the procedure.  Stone ClearTM, which is currently in clinical trials, will help clear the resulting stone fragments within 15 minutes in an office setting and also without general anesthesia or x-ray radiation.

“We are excited to work with the Tech Future Group.  One cannot succeed alone when starting a life science company, and TFG is playing a valuable role in helping startups such as SonoMotion succeed.” 

SonoMotion's EIR:  Mark Klopp  

SonoMotion's EIR: Mark Klopp 

Learn more about SonoMotion:



Posted on February 3, 2016 .